1.
Objective: To optimize dissolution determination of compound famotidine dispersibletablets.
目的:建立复方法莫替丁分散片的溶出度测定方法。
2.
Preparation of famotidine pH-independent sustained release tablets
pH非依赖释放型法莫替丁缓释片的研制
3.
Determination of Ranitidine Hydrochloride in Compound Ranitidine Dispersing Tablet
复方雷尼替丁分散片中盐酸雷尼替丁含量测定研究
4.
Met and Fam group: 0/7,3/7, respectively.
甲硝唑＋法莫替丁组分别为0／7、3/7、0／7。
5.
Determination of famotidine,cimetidine and ranitidine by flow injection chemiluminescence suppression method
流动注射-抑制化学发光法测定法莫替丁、西咪替丁和雷尼替丁
6.
Determination of Enantiomers in Entecavir Dispersible Tablets by HPLC-Chiral Stationary Phase
HPLC法测定恩替卡韦分散片的异构体
7.
Clinical comparison of Famotidine and Omeprazole in the treatment of children gastrointestinal bleeding
法莫替丁与奥美拉唑治疗儿童消化道出血105例对照分析
8.
Effect of Famotidine and Cemitidine on Human Sphincter of Oddi Motility;
法莫替丁及西咪替丁对Oddi括约肌压力变化的影响观察
9.
Treatment of symptoms in gastric acid-related diseases with compound famotidine chewable tablets:evaluation of clinical efficacy and safety
复方法莫替丁咀嚼片治疗胃酸相关性疾病症状的临床疗效及安全性评估
10.
Determination of Dissolution of Nabumetone Dispersible Tablets by HPLC
高效液相色谱法测定萘丁美酮分散片的溶出度
11.
Bacterial endotoxins test of famotidine for injection
注射用法莫替丁细菌内毒素检查法研究
12.
Effect of rebamipide combined with famotidine in the treatment of active gastric ulcer in 61 patients
瑞巴派特联合法莫替丁治疗活动期胃溃疡61例
13.
Effective observation on sucralfate combined with famotidine for treating acute gastritis
硫糖铝联合法莫替丁治疗急性胃炎疗效观察
14.
Observation of Rabeprazole Combined with Famotidine on Gastroesophageal Reflux Disease
雷贝拉唑联合法莫替丁治疗胃食管反流病
15.
Observation on the Efficacy of Draught of Famotidine in 110 Cases of Peptic Ulcer
法莫替丁顿服治疗消化性溃疡110例疗效观察
16.
OPTIMIZATION OF FORMULA AND PREPARATION TECHNOLOGY OF MOXONIDINE DISPERSIBLE TABLETS
莫索尼定分散片处方及制备工艺研究
17.
Determination of famotidine by flow injection chemiluminescence method based on energy transfer to fluorescence substance Rhodamine B
流动注射能量转移荧光素罗丹明B化学发光法测定法莫替丁
18.
Characteristics of Intestinal Absorption and Transport of Famotidine and Effects on Them by Mucosa Protective Agents;
法莫替丁肠吸收特点及粘膜保护剂对其影响的实验研究